Naturalendo Tech Co Ltd Total Assets
Naturalendo Tech Co Ltd total assets. Based on the latest financial reports, Naturalendo Tech Co Ltd (168330) holds total assets worth ₩37.61 Billion KRW (≈ $25.49 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 168330 market cap for the company's overall valuation and market capitalisation.
Total Assets of Naturalendo Tech Co Ltd (2014–2025)
Total assets of Naturalendo Tech Co Ltd from 2014 to 2025. This chart illustrates how Naturalendo Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Naturalendo Tech Co Ltd for real-time trading data and today's change.
Naturalendo Tech Co Ltd - Asset Composition Analysis
Naturalendo Tech Co Ltd Total Assets Breakdown (December 2025)
Naturalendo Tech Co Ltd total assets breakdown as of December 2025. Naturalendo Tech Co Ltd's total assets of ₩37.61 Billion consist of 29.9% current assets and 70.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0.8% |
| Accounts Receivable | ₩2.35 Billion | 6.6% |
| Inventory | ₩6.38 Billion | 17.8% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩483.76 Million | 1.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Naturalendo Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Naturalendo Tech Co Ltd (168330) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Naturalendo Tech Co Ltd's current assets represent 29.9% of total assets in 2025, a decrease from 43.0% in 2014.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2025, down from 17.1% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 17.8% of total assets.
Naturalendo Tech Co Ltd Competitors by Total Assets
Key competitors of Naturalendo Tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sprint Bioscience AB
ST:SPRINT
|
Sweden | Skr118.97 Million |
|
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA
|
USA | $143.94 Million |
|
Klotho Neurosciences, Inc.
NASDAQ:KLTO
|
USA | $10.07 Million |
|
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS
|
USA | $279.04 Million |
|
Neurotech International Ltd
AU:NTI
|
Australia | AU$2.75 Million |
|
Opthea Ltd
AU:OPT
|
Australia | AU$56.54 Million |
|
Synlogic Inc
NASDAQ:SYBX
|
USA | $15.45 Million |
|
Jazz Pharmaceuticals plc
F:J7Z
|
Germany | €11.86 Billion |
Naturalendo Tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.19 | 1.54 | 3.10 |
| Quick Ratio | 0.64 | 0.79 | 2.60 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩1.99 Billion | ₩3.32 Billion | ₩28.84 Billion |
Naturalendo Tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Naturalendo Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.90 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | ₩35.83 Billion |
| Market Capitalization | $44.72 Million USD |
Valuation Analysis
Below Book Valuation: The market values Naturalendo Tech Co Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Naturalendo Tech Co Ltd's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Naturalendo Tech Co Ltd (2014–2025)
The table below shows the annual total assets of Naturalendo Tech Co Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩35.83 Billion ≈ $24.28 Million |
+7.47% |
| 2024-12-31 | ₩33.34 Billion ≈ $22.59 Million |
-10.39% |
| 2023-12-31 | ₩37.20 Billion ≈ $25.21 Million |
-6.55% |
| 2022-12-31 | ₩39.81 Billion ≈ $26.98 Million |
-34.92% |
| 2018-12-31 | ₩61.17 Billion ≈ $41.45 Million |
-28.61% |
| 2017-12-31 | ₩85.68 Billion ≈ $58.07 Million |
-0.22% |
| 2016-12-31 | ₩85.88 Billion ≈ $58.20 Million |
+23.68% |
| 2015-12-31 | ₩69.43 Billion ≈ $47.05 Million |
-21.74% |
| 2014-12-31 | ₩88.72 Billion ≈ $60.12 Million |
-- |
About Naturalendo Tech Co Ltd
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Staun… Read more